Bibliographic Details
| Title: |
CD161⁺ NKT Cell Proportion as a Predictive Biomarker for Bortezomib Treatment Response in Newly Diagnosed Multiple Myeloma Patients. |
| Authors: |
Zhou S, Xu X, Cuo J, Sun C, Hou Y, Wang X, Nana D, Weixun S |
| Source: |
Clinical laboratory [Clin Lab] 2026 May 01; Vol. 72 (5). |
| Publication Type: |
Journal Article |
| Journal Info: |
Publisher: Clinical Laboratory Publications Country of Publication: Germany NLM ID: 9705611 Publication Model: Print Cited Medium: Internet ISSN: 1433-6510 (Print) Linking ISSN: 14336510 NLM ISO Abbreviation: Clin Lab Subsets: MEDLINE |
| Database: |
MEDLINE Ultimate |
